CA2182178A1 - Vaccines against helminthic parasites - Google Patents

Vaccines against helminthic parasites

Info

Publication number: CA2182178A1
Authority: CA; Canada
Prior art keywords: antigen; parasite; variant; precursor; antigens
Prior art date: 1994-03-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002182178A

Other languages

English (en)

French (fr)

Inventor

David Patrick Knox

Stuart Kevin Smith

William David Smith

Diane Redmond

Jacqueline Murray

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Mallinckrodt Veterinary Inc

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-03-25

Filing date

1995-03-24

Publication date

1995-10-05

1994-03-25 Priority claimed from GB9405925A external-priority patent/GB9405925D0/en

1994-03-25 Priority claimed from GB9405990A external-priority patent/GB9405990D0/en

1995-03-24 Application filed by Individual filed Critical Individual

1995-10-05 Publication of CA2182178A1 publication Critical patent/CA2182178A1/en

Status Abandoned legal-status Critical Current

Links

244000045947 parasite Species 0.000 title claims abstract description 54
229960005486 vaccine Drugs 0.000 title claims abstract description 34
239000000427 antigen Substances 0.000 claims abstract description 154
102000036639 antigens Human genes 0.000 claims abstract description 153
108091007433 antigens Proteins 0.000 claims abstract description 153
244000000013 helminth Species 0.000 claims abstract description 53
239000012634 fragment Substances 0.000 claims abstract description 35
230000027455 binding Effects 0.000 claims abstract description 34
230000001681 protective effect Effects 0.000 claims abstract description 30
239000002243 precursor Substances 0.000 claims abstract description 28
241001465754 Metazoa Species 0.000 claims abstract description 25
108010052285 Membrane Proteins Proteins 0.000 claims abstract description 23
102000018697 Membrane Proteins Human genes 0.000 claims abstract description 22
239000000203 mixture Substances 0.000 claims abstract description 20
238000002360 preparation method Methods 0.000 claims abstract description 17
238000011161 development Methods 0.000 claims abstract description 9
230000002401 inhibitory effect Effects 0.000 claims abstract description 8
230000004807 localization Effects 0.000 claims abstract description 6
238000000034 method Methods 0.000 claims description 52
108090000623 proteins and genes Proteins 0.000 claims description 48
102000004169 proteins and genes Human genes 0.000 claims description 43
235000018102 proteins Nutrition 0.000 claims description 42
239000000499 gel Substances 0.000 claims description 37
150000003573 thiols Chemical class 0.000 claims description 33
241001494479 Pecora Species 0.000 claims description 32
125000003729 nucleotide group Chemical group 0.000 claims description 29
108091005804 Peptidases Proteins 0.000 claims description 28
239000002773 nucleotide Substances 0.000 claims description 28
102000035195 Peptidases Human genes 0.000 claims description 27
230000000694 effects Effects 0.000 claims description 27
229920002684 Sepharose Polymers 0.000 claims description 22
108020004707 nucleic acids Proteins 0.000 claims description 21
102000039446 nucleic acids Human genes 0.000 claims description 21
150000007523 nucleic acids Chemical class 0.000 claims description 21
235000019833 protease Nutrition 0.000 claims description 19
239000000758 substrate Substances 0.000 claims description 19
108090000765 processed proteins & peptides Proteins 0.000 claims description 17
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 claims description 17
239000003599 detergent Substances 0.000 claims description 16
102000004196 processed proteins & peptides Human genes 0.000 claims description 16
238000004587 chromatography analysis Methods 0.000 claims description 13
230000028993 immune response Effects 0.000 claims description 13
229920001184 polypeptide Polymers 0.000 claims description 13
238000005406 washing Methods 0.000 claims description 13
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 11
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 claims description 10
241000243795 Ostertagia Species 0.000 claims description 10
235000018417 cysteine Nutrition 0.000 claims description 10
241000243976 Haemonchus Species 0.000 claims description 9
239000004365 Protease Substances 0.000 claims description 9
108091008324 binding proteins Proteins 0.000 claims description 9
230000000295 complement effect Effects 0.000 claims description 9
230000008569 process Effects 0.000 claims description 9
235000019419 proteases Nutrition 0.000 claims description 9
108010010803 Gelatin Proteins 0.000 claims description 8
238000000605 extraction Methods 0.000 claims description 8
239000008273 gelatin Substances 0.000 claims description 8
229920000159 gelatin Polymers 0.000 claims description 8
235000019322 gelatine Nutrition 0.000 claims description 8
235000011852 gelatine desserts Nutrition 0.000 claims description 8
230000004936 stimulating effect Effects 0.000 claims description 8
239000013598 vector Substances 0.000 claims description 8
239000000287 crude extract Substances 0.000 claims description 7
241000191771 Teladorsagia circumcincta Species 0.000 claims description 6
241000283690 Bos taurus Species 0.000 claims description 5
241000282849 Ruminantia Species 0.000 claims description 5
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 5
238000010828 elution Methods 0.000 claims description 5
239000003085 diluting agent Substances 0.000 claims description 4
239000003937 drug carrier Substances 0.000 claims description 4
239000013604 expression vector Substances 0.000 claims description 4
230000002797 proteolythic effect Effects 0.000 claims description 4
GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical group [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 claims description 4
241000283707 Capra Species 0.000 claims description 2
241000124008 Mammalia Species 0.000 claims description 2
238000012258 culturing Methods 0.000 claims description 2
230000000673 metalloproteinaselike Effects 0.000 claims description 2
230000000638 stimulation Effects 0.000 claims description 2
-1 variant Substances 0.000 claims 15
241000243974 Haemonchus contortus Species 0.000 claims 3
102000023732 binding proteins Human genes 0.000 claims 2
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 1
239000013599 cloning vector Substances 0.000 claims 1
230000000890 antigenic effect Effects 0.000 abstract description 9
108091028043 Nucleic acid sequence Proteins 0.000 abstract description 5
238000004519 manufacturing process Methods 0.000 abstract description 4
125000003396 thiol group Chemical class [H]S* 0.000 abstract description 2
241000283903 Ovis aries Species 0.000 description 43
235000013601 eggs Nutrition 0.000 description 24
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 21
239000013615 primer Substances 0.000 description 21
108020004414 DNA Proteins 0.000 description 20
150000001413 amino acids Chemical group 0.000 description 19
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
238000004458 analytical method Methods 0.000 description 17
239000000872 buffer Substances 0.000 description 16
108010005843 Cysteine Proteases Proteins 0.000 description 15
101100062312 Haemonchus contortus AC-1 gene Proteins 0.000 description 15
102000005927 Cysteine Proteases Human genes 0.000 description 14
239000002299 complementary DNA Substances 0.000 description 14
239000000284 extract Substances 0.000 description 14
KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 14
239000000047 product Substances 0.000 description 14
239000002671 adjuvant Substances 0.000 description 13
208000015181 infectious disease Diseases 0.000 description 13
230000002829 reductive effect Effects 0.000 description 12
241000244206 Nematoda Species 0.000 description 11
210000001035 gastrointestinal tract Anatomy 0.000 description 11
239000012528 membrane Substances 0.000 description 11
239000011780 sodium chloride Substances 0.000 description 11
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 10
108090001090 Lectins Proteins 0.000 description 10
102000004856 Lectins Human genes 0.000 description 10
238000002649 immunization Methods 0.000 description 10
239000002523 lectin Substances 0.000 description 10
YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 10
235000019687 Lamb Nutrition 0.000 description 9
210000004027 cell Anatomy 0.000 description 9
238000006243 chemical reaction Methods 0.000 description 9
238000005119 centrifugation Methods 0.000 description 8
238000002474 experimental method Methods 0.000 description 8
239000000463 material Substances 0.000 description 8
102000014914 Carrier Proteins Human genes 0.000 description 7
102000053602 DNA Human genes 0.000 description 7
240000007860 Heteropogon contortus Species 0.000 description 7
239000007983 Tris buffer Substances 0.000 description 7
235000001014 amino acid Nutrition 0.000 description 7
230000005875 antibody response Effects 0.000 description 7
238000010367 cloning Methods 0.000 description 7
230000013595 glycosylation Effects 0.000 description 7
238000006206 glycosylation reaction Methods 0.000 description 7
238000002347 injection Methods 0.000 description 7
239000007924 injection Substances 0.000 description 7
230000017854 proteolysis Effects 0.000 description 7
239000006228 supernatant Substances 0.000 description 7
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 7
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
108060003951 Immunoglobulin Proteins 0.000 description 6
239000013504 Triton X-100 Substances 0.000 description 6
229920004890 Triton X-100 Polymers 0.000 description 6
241000700605 Viruses Species 0.000 description 6
229940024606 amino acid Drugs 0.000 description 6
210000004369 blood Anatomy 0.000 description 6
239000008280 blood Substances 0.000 description 6
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 6
102000018358 immunoglobulin Human genes 0.000 description 6
238000011534 incubation Methods 0.000 description 6
239000002953 phosphate buffered saline Substances 0.000 description 6
230000004044 response Effects 0.000 description 6
238000001262 western blot Methods 0.000 description 6
108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
108010062580 Concanavalin A Proteins 0.000 description 5
230000000692 anti-sense effect Effects 0.000 description 5
229940019748 antifibrinolytic proteinase inhibitors Drugs 0.000 description 5
108010041102 azocasein Proteins 0.000 description 5
230000036039 immunity Effects 0.000 description 5
239000003112 inhibitor Substances 0.000 description 5
108020004999 messenger RNA Proteins 0.000 description 5
239000000137 peptide hydrolase inhibitor Substances 0.000 description 5
239000000243 solution Substances 0.000 description 5
238000010186 staining Methods 0.000 description 5
230000009261 transgenic effect Effects 0.000 description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
235000017060 Arachis glabrata Nutrition 0.000 description 4
244000105624 Arachis hypogaea Species 0.000 description 4
235000010777 Arachis hypogaea Nutrition 0.000 description 4
235000018262 Arachis monticola Nutrition 0.000 description 4
241000219764 Dolichos Species 0.000 description 4
241000237369 Helix pomatia Species 0.000 description 4
108010034145 Helminth Proteins Proteins 0.000 description 4
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
238000000636 Northern blotting Methods 0.000 description 4
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
108020004511 Recombinant DNA Proteins 0.000 description 4
238000002105 Southern blotting Methods 0.000 description 4
238000000692 Student's t-test Methods 0.000 description 4
230000003321 amplification Effects 0.000 description 4
239000008346 aqueous phase Substances 0.000 description 4
201000010099 disease Diseases 0.000 description 4
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 4
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 4
238000009396 hybridization Methods 0.000 description 4
230000001524 infective effect Effects 0.000 description 4
108010084553 jacalin Proteins 0.000 description 4
238000003199 nucleic acid amplification method Methods 0.000 description 4
235000020232 peanut Nutrition 0.000 description 4
239000008188 pellet Substances 0.000 description 4
230000009257 reactivity Effects 0.000 description 4
239000000523 sample Substances 0.000 description 4
210000002966 serum Anatomy 0.000 description 4
241000894007 species Species 0.000 description 4
101710186708 Agglutinin Proteins 0.000 description 3
241001041929 Bathyomphalus contortus Species 0.000 description 3
108010062466 Enzyme Precursors Proteins 0.000 description 3
102000010911 Enzyme Precursors Human genes 0.000 description 3
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
244000068988 Glycine max Species 0.000 description 3
235000010469 Glycine max Nutrition 0.000 description 3
102000003886 Glycoproteins Human genes 0.000 description 3
108090000288 Glycoproteins Proteins 0.000 description 3
101710146024 Horcolin Proteins 0.000 description 3
101710189395 Lectin Proteins 0.000 description 3
101710179758 Mannose-specific lectin Proteins 0.000 description 3
101710150763 Mannose-specific lectin 1 Proteins 0.000 description 3
101710150745 Mannose-specific lectin 2 Proteins 0.000 description 3
108091034117 Oligonucleotide Proteins 0.000 description 3
229920001213 Polysorbate 20 Polymers 0.000 description 3
238000002123 RNA extraction Methods 0.000 description 3
239000000910 agglutinin Substances 0.000 description 3
238000003556 assay Methods 0.000 description 3
238000012217 deletion Methods 0.000 description 3
239000011536 extraction buffer Substances 0.000 description 3
230000001900 immune effect Effects 0.000 description 3
230000000968 intestinal effect Effects 0.000 description 3
238000009304 pastoral farming Methods 0.000 description 3
FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 description 3
239000013600 plasmid vector Substances 0.000 description 3
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
239000001509 sodium citrate Substances 0.000 description 3
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
238000012360 testing method Methods 0.000 description 3
229940125575 vaccine candidate Drugs 0.000 description 3
230000003442 weekly effect Effects 0.000 description 3
PDJMCBVRNSWEOY-UHFFFAOYSA-N 1-[3-(3-acetyl-2-hydroxy-4,6-dimethoxy-5-methylphenyl)-2-hydroxy-4,6-dimethoxy-5-methylphenyl]ethanone Chemical compound OC1=C(C(C)=O)C(OC)=C(C)C(OC)=C1C1=C(O)C(C(C)=O)=C(OC)C(C)=C1OC PDJMCBVRNSWEOY-UHFFFAOYSA-N 0.000 description 2
QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
108020004705 Codon Proteins 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
208000034454 F12-related hereditary angioedema with normal C1Inh Diseases 0.000 description 2
208000006968 Helminthiasis Diseases 0.000 description 2
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
102000005741 Metalloproteases Human genes 0.000 description 2
108010006035 Metalloproteases Proteins 0.000 description 2
108091061960 Naked DNA Proteins 0.000 description 2
238000012408 PCR amplification Methods 0.000 description 2
241000803553 Rhinodrilus contortus Species 0.000 description 2
108091006629 SLC13A2 Proteins 0.000 description 2
108010022999 Serine Proteases Proteins 0.000 description 2
102000012479 Serine Proteases Human genes 0.000 description 2
239000006180 TBST buffer Substances 0.000 description 2
108020005038 Terminator Codon Proteins 0.000 description 2
241000209140 Triticum Species 0.000 description 2
235000021307 Triticum Nutrition 0.000 description 2
206010046865 Vaccinia virus infection Diseases 0.000 description 2
QPMSXSBEVQLBIL-CZRHPSIPSA-N ac1mix0p Chemical compound C1=CC=C2N(C[C@H](C)CN(C)C)C3=CC(OC)=CC=C3SC2=C1.O([C@H]1[C@]2(OC)C=CC34C[C@@H]2[C@](C)(O)CCC)C2=C5[C@]41CCN(C)[C@@H]3CC5=CC=C2O QPMSXSBEVQLBIL-CZRHPSIPSA-N 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
239000011543 agarose gel Substances 0.000 description 2
230000000507 anthelmentic effect Effects 0.000 description 2
238000010804 cDNA synthesis Methods 0.000 description 2
238000012512 characterization method Methods 0.000 description 2
230000009260 cross reactivity Effects 0.000 description 2
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
230000037430 deletion Effects 0.000 description 2
230000029087 digestion Effects 0.000 description 2
229940079593 drug Drugs 0.000 description 2
239000003814 drug Substances 0.000 description 2
238000001962 electrophoresis Methods 0.000 description 2
229940088598 enzyme Drugs 0.000 description 2
239000006167 equilibration buffer Substances 0.000 description 2
210000003527 eukaryotic cell Anatomy 0.000 description 2
210000003608 fece Anatomy 0.000 description 2
238000009472 formulation Methods 0.000 description 2
230000004927 fusion Effects 0.000 description 2
108020001507 fusion proteins Proteins 0.000 description 2
102000037865 fusion proteins Human genes 0.000 description 2
230000002496 gastric effect Effects 0.000 description 2
125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 2
208000016861 hereditary angioedema type 3 Diseases 0.000 description 2
238000000265 homogenisation Methods 0.000 description 2
PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
238000002955 isolation Methods 0.000 description 2
239000007788 liquid Substances 0.000 description 2
210000003141 lower extremity Anatomy 0.000 description 2
210000000110 microvilli Anatomy 0.000 description 2
238000010369 molecular cloning Methods 0.000 description 2
239000012074 organic phase Substances 0.000 description 2
230000003071 parasitic effect Effects 0.000 description 2
208000014837 parasitic helminthiasis infectious disease Diseases 0.000 description 2
229950000964 pepstatin Drugs 0.000 description 2
108010091212 pepstatin Proteins 0.000 description 2
VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
230000002093 peripheral effect Effects 0.000 description 2
239000013612 plasmid Substances 0.000 description 2
229920002401 polyacrylamide Polymers 0.000 description 2
210000001236 prokaryotic cell Anatomy 0.000 description 2
108091008146 restriction endonucleases Proteins 0.000 description 2
230000000717 retained effect Effects 0.000 description 2
238000005070 sampling Methods 0.000 description 2
238000012163 sequencing technique Methods 0.000 description 2
JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
239000000126 substance Substances 0.000 description 2
238000012546 transfer Methods 0.000 description 2
241000701161 unidentified adenovirus Species 0.000 description 2
238000002255 vaccination Methods 0.000 description 2
208000007089 vaccinia Diseases 0.000 description 2
239000003981 vehicle Substances 0.000 description 2
239000013603 viral vector Substances 0.000 description 2
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
108010042708 Acetylmuramyl-Alanyl-Isoglutamine Proteins 0.000 description 1
241000014654 Adna Species 0.000 description 1
241001147657 Ancylostoma Species 0.000 description 1
208000002109 Argyria Diseases 0.000 description 1
241000244186 Ascaris Species 0.000 description 1
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
241000972773 Aulopiformes Species 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
241000931178 Bunostomum Species 0.000 description 1
241000244202 Caenorhabditis Species 0.000 description 1
101710132601 Capsid protein Proteins 0.000 description 1
101710163595 Chaperone protein DnaK Proteins 0.000 description 1
108091026890 Coding region Proteins 0.000 description 1
108091035707 Consensus sequence Proteins 0.000 description 1
102100028007 Cystatin-SA Human genes 0.000 description 1
101710144510 Cysteine proteinase inhibitor Proteins 0.000 description 1
230000004544 DNA amplification Effects 0.000 description 1
239000003155 DNA primer Substances 0.000 description 1
206010011878 Deafness Diseases 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
206010059866 Drug resistance Diseases 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
108010067770 Endopeptidase K Proteins 0.000 description 1
108050001049 Extracellular proteins Proteins 0.000 description 1
102000006485 Glutamyl Aminopeptidase Human genes 0.000 description 1
108010058940 Glutamyl Aminopeptidase Proteins 0.000 description 1
102000005720 Glutathione transferase Human genes 0.000 description 1
108010070675 Glutathione transferase Proteins 0.000 description 1
108010001336 Horseradish Peroxidase Proteins 0.000 description 1
XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
229930010555 Inosine Natural products 0.000 description 1
UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
101001060713 Leptospira interrogans serogroup Icterohaemorrhagiae serovar Lai (strain 56601) Flagellar filament 35 kDa core protein Proteins 0.000 description 1
241000243789 Metastrongyloidea Species 0.000 description 1
241000556230 Metastrongylus Species 0.000 description 1
101001013152 Mycobacterium avium Major membrane protein 1 Proteins 0.000 description 1
101001013151 Mycobacterium leprae (strain TN) Major membrane protein I Proteins 0.000 description 1
GHAZCVNUKKZTLG-UHFFFAOYSA-N N-ethyl-succinimide Natural products CCN1C(=O)CCC1=O GHAZCVNUKKZTLG-UHFFFAOYSA-N 0.000 description 1
HDFGOPSGAURCEO-UHFFFAOYSA-N N-ethylmaleimide Chemical compound CCN1C(=O)C=CC1=O HDFGOPSGAURCEO-UHFFFAOYSA-N 0.000 description 1
102000003729 Neprilysin Human genes 0.000 description 1
108090000028 Neprilysin Proteins 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
208000030852 Parasitic disease Diseases 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
102000057297 Pepsin A Human genes 0.000 description 1
108090000284 Pepsin A Proteins 0.000 description 1
108010047320 Pepsinogen A Proteins 0.000 description 1
101710194807 Protective antigen Proteins 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
241000607142 Salmonella Species 0.000 description 1
241000242678 Schistosoma Species 0.000 description 1
108020004682 Single-Stranded DNA Proteins 0.000 description 1
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
108010090804 Streptavidin Proteins 0.000 description 1
101000638142 Treponema pallidum (strain Nichols) Membrane lipoprotein TmpC Proteins 0.000 description 1
241001489151 Trichuris Species 0.000 description 1
UZQJVUCHXGYFLQ-AYDHOLPZSA-N [(2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-4-[(2r,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-6-(hy Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O)O[C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2[C@@]1(C=O)C)C)(C)CC(O)[C@]1(CCC(CC14)(C)C)C(=O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O[C@H]4[C@@H]([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)[C@H](O)[C@@H](CO)O4)O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UZQJVUCHXGYFLQ-AYDHOLPZSA-N 0.000 description 1
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
GPKUGWDQUVWHIC-UHFFFAOYSA-N [4-(4-hydrazinylphenyl)phenyl]hydrazine tetrahydrochloride Chemical compound Cl.Cl.Cl.Cl.NNC1=CC=C(C=C1)C1=CC=C(NN)C=C1 GPKUGWDQUVWHIC-UHFFFAOYSA-N 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
239000008351 acetate buffer Substances 0.000 description 1
230000003044 adaptive effect Effects 0.000 description 1
238000001042 affinity chromatography Methods 0.000 description 1
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
229910021502 aluminium hydroxide Inorganic materials 0.000 description 1
238000003277 amino acid sequence analysis Methods 0.000 description 1
238000000540 analysis of variance Methods 0.000 description 1
238000000137 annealing Methods 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
238000013459 approach Methods 0.000 description 1
229960001230 asparagine Drugs 0.000 description 1
235000009582 asparagine Nutrition 0.000 description 1
125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 description 1
229940009098 aspartate Drugs 0.000 description 1
230000002238 attenuated effect Effects 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
229920001400 block copolymer Polymers 0.000 description 1
230000023555 blood coagulation Effects 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
239000000969 carrier Substances 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
230000008859 change Effects 0.000 description 1
239000013522 chelant Substances 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
239000002852 cysteine proteinase inhibitor Substances 0.000 description 1
230000009089 cytolysis Effects 0.000 description 1
230000034994 death Effects 0.000 description 1
230000022811 deglycosylation Effects 0.000 description 1
238000009826 distribution Methods 0.000 description 1
229960001484 edetic acid Drugs 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
229960005542 ethidium bromide Drugs 0.000 description 1
230000001471 fibrinogenolytic effect Effects 0.000 description 1
229930182830 galactose Natural products 0.000 description 1
210000004602 germ cell Anatomy 0.000 description 1
102000018146 globin Human genes 0.000 description 1
108060003196 globin Proteins 0.000 description 1
208000037824 growth disorder Diseases 0.000 description 1
YQOKLYTXVFAUCW-UHFFFAOYSA-N guanidine;isothiocyanic acid Chemical compound N=C=S.NC(N)=N YQOKLYTXVFAUCW-UHFFFAOYSA-N 0.000 description 1
208000006454 hepatitis Diseases 0.000 description 1
231100000283 hepatitis Toxicity 0.000 description 1
238000005286 illumination Methods 0.000 description 1
239000012642 immune effector Substances 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
229940121354 immunomodulator Drugs 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
229960003786 inosine Drugs 0.000 description 1
239000002198 insoluble material Substances 0.000 description 1
238000010255 intramuscular injection Methods 0.000 description 1
239000007927 intramuscular injection Substances 0.000 description 1
JDNTWHVOXJZDSN-UHFFFAOYSA-N iodoacetic acid Chemical compound OC(=O)CI JDNTWHVOXJZDSN-UHFFFAOYSA-N 0.000 description 1
238000004255 ion exchange chromatography Methods 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
244000144972 livestock Species 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
239000003550 marker Substances 0.000 description 1
230000007102 metabolic function Effects 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
244000005700 microbiome Species 0.000 description 1
239000002480 mineral oil Substances 0.000 description 1
239000004570 mortar (masonry) Substances 0.000 description 1
BSOQXXWZTUDTEL-ZUYCGGNHSA-N muramyl dipeptide Chemical compound OC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]1NC(C)=O BSOQXXWZTUDTEL-ZUYCGGNHSA-N 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
206010033675 panniculitis Diseases 0.000 description 1
230000036281 parasite infection Effects 0.000 description 1
230000003108 parasitologic effect Effects 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
229940111202 pepsin Drugs 0.000 description 1
238000010647 peptide synthesis reaction Methods 0.000 description 1
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
238000003752 polymerase chain reaction Methods 0.000 description 1
229920000136 polysorbate Polymers 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
238000012545 processing Methods 0.000 description 1
230000006337 proteolytic cleavage Effects 0.000 description 1
239000001397 quillaja saponaria molina bark Substances 0.000 description 1
238000002708 random mutagenesis Methods 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
210000003705 ribosome Anatomy 0.000 description 1
235000019515 salmon Nutrition 0.000 description 1
229930182490 saponin Natural products 0.000 description 1
150000007949 saponins Chemical class 0.000 description 1
230000007017 scission Effects 0.000 description 1
230000028327 secretion Effects 0.000 description 1
230000011664 signaling Effects 0.000 description 1
238000002741 site-directed mutagenesis Methods 0.000 description 1
239000001632 sodium acetate Substances 0.000 description 1
235000017281 sodium acetate Nutrition 0.000 description 1
PXIPVTKHYLBLMZ-UHFFFAOYSA-N sodium azide Substances [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 1
238000010532 solid phase synthesis reaction Methods 0.000 description 1
210000001082 somatic cell Anatomy 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
239000007858 starting material Substances 0.000 description 1
239000008223 sterile water Substances 0.000 description 1
238000003860 storage Methods 0.000 description 1
229960005322 streptomycin Drugs 0.000 description 1
239000007929 subcutaneous injection Substances 0.000 description 1
238000010254 subcutaneous injection Methods 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
238000001890 transfection Methods 0.000 description 1
230000009466 transformation Effects 0.000 description 1
241000701447 unidentified baculovirus Species 0.000 description 1
241001515965 unidentified phage Species 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
- C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Wood Science & Technology (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Tropical Medicine & Parasitology (AREA)
Toxicology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Biophysics (AREA)
General Engineering & Computer Science (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

CA002182178A 1994-03-25 1995-03-24 Vaccines against helminthic parasites Abandoned CA2182178A1 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB9405925A GB9405925D0 (en)	1994-03-25	1994-03-25	Vaccines
GB9405925.0		1994-03-25
GB9405990A GB9405990D0 (en)	1994-03-25	1994-03-25	Vaccines
GB9405990.4		1994-03-25

Publications (1)

Publication Number	Publication Date
CA2182178A1 true CA2182178A1 (en)	1995-10-05

Family

ID=26304584

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002182178A Abandoned CA2182178A1 (en)	1994-03-25	1995-03-24	Vaccines against helminthic parasites

Country Status (5)

Country	Link
EP (1)	EP0804570A1 (de)
AU (1)	AU701642B2 (de)
CA (1)	CA2182178A1 (de)
MX (1)	MX9604182A (de)
WO (1)	WO1995026402A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6017757A (en) *	1997-02-20	2000-01-25	Mississippi State University	Isolated viable nematode intestinal cells
KR100900837B1 (ko)	2007-12-07	2009-06-04	(주)두비엘	리포펩타이드와 폴리(ｉ:ｃ)를 아쥬반트로 포함하는 강력한백신 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZW8893A1 (en) *	1992-07-21	1994-06-01	Pitman Moore Inc	Vaccines

1995
- 1995-03-24 CA CA002182178A patent/CA2182178A1/en not_active Abandoned
- 1995-03-24 EP EP95912351A patent/EP0804570A1/de not_active Withdrawn
- 1995-03-24 MX MX9604182A patent/MX9604182A/es unknown
- 1995-03-24 AU AU19564/95A patent/AU701642B2/en not_active Ceased
- 1995-03-24 WO PCT/GB1995/000665 patent/WO1995026402A1/en not_active Ceased

Also Published As

Publication number	Publication date
MX9604182A (es)	1997-12-31
AU1956495A (en)	1995-10-17
EP0804570A1 (de)	1997-11-05
WO1995026402A1 (en)	1995-10-05
AU701642B2 (en)	1999-02-04

Legal Events

Date	Code	Title	Description
2002-03-22	EEER	Examination request
2011-03-24	FZDE	Discontinued

Publication	Publication Date	Title
US4973551A (en)	1990-11-27	Vector for the expression of fusion proteins and protein immunogens
US7968695B2 (en)	2011-06-28	Nucleic acids encoding recombinant 56 and 82 kDa antigens from gametocytes of Eimeria maxima and their uses
EP0391997A1 (de)	1990-10-17	Impfstoff
CA1340301C (en)	1999-01-05	Vaccines against animal parasitic nematodes
JPH07508879A (ja)	1995-10-05	アミノペプチダーゼ酵素をコードする組換えｄｎａ分子および蠕虫感染に対するワクチンの調製におけるその用途
JPS6169798A (ja)	1986-04-10	コクシジウムのモノクロ−ナル抗体
IE62866B1 (en)	1995-03-08	Recombinant and native group b eimeria tenella immunogens useful as coccidiosis vaccines
AU636290B2 (en)	1993-04-29	Recombinant eimeria tenella vaccines
JP4209466B2 (ja)	2009-01-14	血管作用性アミン結合分子
KR20000065265A (ko)	2000-11-06	말라리아 원충 msp-1의 c-말단 단편을 함유하는 재조합 단백질
US8227584B2 (en)	2012-07-24	Ostertagia vaccine
EP0652769B1 (de)	1996-03-06	Impfstoffe gegen Metazoen-Parasiten
AU701642B2 (en)	1999-02-04	Vaccines against helminthic parasites
EP0434909A2 (de)	1991-07-03	Antikoagulierende und antihelmintische Proteine, und Verfahren zu ihrer Herstellung und ihre Verwendung
US5650154A (en)	1997-07-22	Protective antigens against disease pathogens
US6413521B1 (en)	2002-07-02	Helminth parasite antigen with aminopeptidase-like activity
US20030129204A1 (en)	2003-07-10	Vaccines against helminthic parasites
US5843710A (en)	1998-12-01	Vaccines against animal parasitic nematodes
WO1995012679A1 (en)	1995-05-11	Anti-helminth vaccines
JP2002247989A (ja)	2002-09-03	豚回虫（Ａｓｃａｒｉｓｓｕｕｍ）感染幼虫の１４ｋＤａ抗原、それをコードする核酸分子及びそれらの利用